Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ARID3A |
| Upstream (Parents) |
|---|
| (<<) LY6G6D → ARID3A |
| (<<) IGF2BP2 → ARID3A |
| (<<) PLAGL2 → ARID3A |
| (<<) CPNE1 → ARID3A |
| Downstream (Children) |
|---|
| ARID3A → WIF1 (>>) |
| ARID3A → COL9A3 (>>) |
| ARID3A → CDH6 (>>) |
| ARID3A → GABRA2 (>>) |
| ARID3A → H2AFY2 (>>) |
| ARID3A → GDPD5 (>>) |
| ARID3A → IL1R2 (>>) |
| ARID3A → PRPH2 (>>) |
| ARID3A → ID1 (>>) |
| ARID3A → MLPH (>>) |
| ARID3A → C5orf42 (>>) |
| ARID3A → SECTM1 (>>) |
| ARID3A → STRN3 (>>) |
